VI
Vestcor Inc Portfolio holdings
AUM
$3.35B
1-Year Est. Return
19.59%
1 Year Est. Return
+19.59%
AUM
$3.31B
AUM Growth
+$335M
(+11%)
Holding
1,258
Top Buys
| 1 | +$12.7M | |
| 2 | +$10.4M | |
| 3 | +$9.92M | |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$8.93M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$8.87M |
Top Sells
| 1 | +$16.9M | |
| 2 | +$12.5M | |
| 3 | +$9.91M | |
| 4 |
Hershey
HSY
|
+$8.39M |
| 5 |
Marathon Petroleum
MPC
|
+$8.25M |
Sector Composition
| 1 | Technology | 24.22% |
| 2 | Financials | 10.93% |
| 3 | Healthcare | 10.69% |
| 4 | Consumer Staples | 10.68% |
| 5 | Consumer Discretionary | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Cheniere Energy
LNG
$46.3B
| $3.03M | 0.09% |
12,448
+3,257
|
|
||
252
Kimbell Royalty Partners
KRP
$1.29B
| $3.01M | 0.09% |
215,635
|
|
||
253
Church & Dwight Co
CHD
$20.2B
| $3.01M | 0.09% |
31,293
+884
|
|
||
254
PPL Corp
PPL
$27.2B
| $3M | 0.09% |
88,588
+24,701
|
|
||
255
Veeva Systems
VEEV
$48.1B
| $3M | 0.09% |
10,416
+7,692
|
|
||
256
Tanger
SKT
$3.91B
| $2.99M | 0.09% |
97,858
-9,339
|
|
||
257
Essential Properties Realty Trust
EPRT
$6.11B
| $2.93M | 0.09% |
91,854
+1,764
|
|
||
258
Rollins
ROL
$28B
| $2.93M | 0.09% |
51,912
-29
|
|
||
259
Fox Class A
FOXA
$28.8B
| $2.89M | 0.09% |
51,587
+43,490
|
|
||
260
Pfizer
PFE
$142B
| $2.85M | 0.09% |
117,543
+8,824
|
|
||
261
Eaton
ETN
$137B
| $2.84M | 0.09% |
7,950
+570
|
|
||
262
Ingles Markets
IMKTA
$1.42B
| $2.83M | 0.09% |
44,714
-37,181
|
|
||
263
COPT Defense Properties
CDP
$3.27B
| $2.74M | 0.08% |
99,489
-9,504
|
|
||
264
Burlington
BURL
$17.6B
| $2.73M | 0.08% |
11,738
+4,028
|
|
||
265
Deere & Co
DE
$129B
| $2.73M | 0.08% |
5,359
+347
|
|
||
266
Capital One
COF
$134B
| $2.72M | 0.08% |
12,785
+5,205
|
|
||
|
AZEK
267
DELISTED
The AZEK Co
AZEK
| $2.72M | 0.08% |
50,000
|
|
||
268
Paylocity
PCTY
$8.05B
| $2.72M | 0.08% |
15,000
-5,000
|
|
||
269
Stryker
SYK
$139B
| $2.72M | 0.08% |
6,871
+501
|
|
||
270
Neurocrine Biosciences
NBIX
$14.4B
| $2.7M | 0.08% |
21,514
+83
|
|
||
271
CVS Health
CVS
$98.8B
| $2.69M | 0.08% |
39,008
+15,171
|
|
||
272
Mettler-Toledo International
MTD
$28.7B
| $2.69M | 0.08% |
2,289
-28
|
|
||
273
Chubb
CB
$116B
| $2.68M | 0.08% |
9,251
+2,093
|
|
||
274
Danaher
DHR
$156B
| $2.68M | 0.08% |
13,567
+917
|
|
||
275
Ubiquiti
UI
$33.8B
| $2.66M | 0.08% |
6,460
+4,190
|
|